Skip to content

Drug interactions

Berotralstat + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Moderate

Berotralstat and Sofosbuvir-velpatasvir-voxilaprevir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Berotralstat inhibits P-glycoprotein and may raise exposure to velpatasvir, voxilaprevir and sofosbuvir, which are P-gp substrates. The combination may also raise berotralstat levels through transporter effects. The increases are usually modest and manageable.

What this interaction means in plain words

Berotralstat and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Berotralstat belongs to Miscellaneous; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Mutual inhibition of P-glycoprotein (and possibly other transporters) reduces efflux and increases systemic exposure of the substrates.

What to do

Coadminister with monitoring for adverse effects of both products, including berotralstat GI effects and QT-related symptoms. Consider ECG monitoring if the patient has other QT risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as moderate. Berotralstat and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Berotralstat inhibits P-glycoprotein and may raise exposure to velpatasvir, voxilaprevir and sofosbuvir, which are P-gp substrates. The combination may also raise berotralstat levels through transporter effects. The increases are usually modest and manageable.

How serious is the interaction between Berotralstat and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Coadminister with monitoring for adverse effects of both products, including berotralstat GI effects and QT-related symptoms. Consider ECG monitoring if the patient has other QT risk factors.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in